findmyKOL
Clinical trialNCT02407028RecruitingPhase 2Interventional

Hyperbaric Oxygen Brain Injury Treatment Trial

SponsorGaylan RockswoldEnrollment200Traumatic Brain Injury
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this innovative adaptive phase II trial design is to determine the optimal combination of hyperbaric oxygen treatment parameters that is most likely to demonstrate improvement in the outcome of severe TBI patients in a subsequent phase III trial.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Hamilton Heath Services

    Hamilton, Ontario, Canada

    Completed
United States
  • Ucsd Medical Center - Hillcrest Hospital

    San Diego, California, United States

    Jessica Weaver, MD
    Recruiting
  • St. Mary'S Medical Center

    West Palm Beach, Florida, United States

    Faris Azar, MD
    Recruiting
  • University of Iowa Hospitals and Clinics

    Iowa City, Iowa, United States

    Nicholas Mohr, MD
    Recruiting
  • University of Kentucky Hospital

    Lexington, Kentucky, United States

    David Dornbos, MD
    Recruiting
  • University of Maryland

    Baltimore, Maryland, United States

    Kinjal Sethuraman, MD
    Recruiting
  • Detroit Receiving Hospital

    Detroit, Michigan, United States

    Anthony Lagina, MD
    Recruiting
  • Hennepin County Hospital

    Minneapolis, Minnesota, United States

    Sam Cramer, MD, PhD
    Recruiting
  • University of Nebraska Medical Center

    Omaha, Nebraska, United States

    Completed
  • Duke University Hospital

    Durham, North Carolina, United States

    Katherine Colton, MD
    Recruiting
  • the Ohio State University Wexner Medical Center

    Columbus, Ohio, United States

    Completed

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Hyperbaric oxygenNormobaric Hyperoxia
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
25 Jun 2018
Primary completion
26 Oct 2028
Completion
30 Jun 2029
Last update posted
2 Jun 2026
Registered enrollment
200
Registry id
NCT02407028

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.